Lee Capital Holdings’s Eli Lilly LLY Stock Holding History

Lee Capital Holdings’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,200	Closed	-$598K	–	70
2021 Q1	$598K	Buy	+3,200	New	+$626K	0.26%	76

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Lee Capital Holdings's LLY Position: Q2 2021 in Review

Lee Capital Holdings sold out of Eli Lilly (LLY) in Q2 2021, closing a stake of 3,200 shares — an estimated $598K sold.

Lee Capital Holdings first reported a position in LLY in Q1 2021 and held it in 1 quarter. The position peaked at $598K in Q1 2021. 2,022 funds tracked by Wall St. Rank hold LLY as of Q2 2021.

Lee Capital Holdings reported no remaining Eli Lilly position as of Q2 2021 after selling out during the quarter.
Lee Capital Holdings sold 3,200 Eli Lilly shares in Q2 2021, an estimated $598K.
Lee Capital Holdings first reported a position in Eli Lilly in Q1 2021 and held it in 1 quarter.
Lee Capital Holdings's Eli Lilly position peaked at $598K in Q1 2021.
2,022 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2021.

Based on Lee Capital Holdings's 13F filing for Q2 2021, filed 16 Aug 2021.